Type 1, Type 2 Myocardial Infarction and Non-Ischemic Myocardial Injury-Opinion from the Front Lines.
Alpert JS, Jaffe AS, White HD, Thygesen KA.
Am J Med. 2022 Aug;135(8):935-938. doi: 10.1016/j.amjmed.2022.03.004. Epub 2022 Mar 25.
PMID:35341772
Impact of Acute Myocardial Infarction Type on Prognosis in Female Patients With Cardiogenic Shock.
Jeon BK, Jang WJ, Park IH, Oh JH, Yang JH, Gwon HC, Ahn CM, Yu CW, Kim HJ, Bae JW, Kwon SU, Lee HJ, Lee WS, Jeong JO, Park SD.
Am J Cardiol. 2023 Nov 1;206:116-124. doi: 10.1016/j.amjcard.2023.08.009. Epub 2023 Sep 8.
PMID:37690149
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.
Keeley EC, Boura JA, Grines CL.
Lancet. 2003 Jan 4;361(9351):13-20. doi: 10.1016/S0140-6736(03)12113-7.
PMID:12517460
Timing of SGLT2i initiation after acute myocardial infarction.
von Lewinski D, Kolesnik E, Aziz F, Benedikt M, Tripolt NJ, Wallner M, Pferschy PN, von Lewinski F, Schwegel N, Holman RR, Oulhaj A, Moertl D, Siller-Matula J, Sourij H.